Ken Griffin’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $179K | Buy |
+15,841
| New | +$179K | ﹤0.01% | 5045 |
|
2025
Q1 | – | Sell |
-136,493
| Closed | -$1.16M | – | 6469 |
|
2024
Q4 | $1.16M | Buy |
136,493
+9,244
| +7% | +$78.3K | ﹤0.01% | 3125 |
|
2024
Q3 | $1.47M | Buy |
127,249
+108,427
| +576% | +$1.26M | ﹤0.01% | 2759 |
|
2024
Q2 | $222K | Sell |
18,822
-68,262
| -78% | -$804K | ﹤0.01% | 4560 |
|
2024
Q1 | $1.03M | Sell |
87,084
-696,614
| -89% | -$8.26M | ﹤0.01% | 3154 |
|
2023
Q4 | $9.6M | Sell |
783,698
-144,804
| -16% | -$1.77M | ﹤0.01% | 1256 |
|
2023
Q3 | $8.94M | Buy |
928,502
+81,896
| +10% | +$789K | ﹤0.01% | 1228 |
|
2023
Q2 | $7.62M | Buy |
846,606
+718,211
| +559% | +$6.46M | ﹤0.01% | 1397 |
|
2023
Q1 | $1.01M | Buy |
128,395
+26,868
| +26% | +$211K | ﹤0.01% | 3180 |
|
2022
Q4 | $686K | Sell |
101,527
-37,995
| -27% | -$257K | ﹤0.01% | 3563 |
|
2022
Q3 | $2.02M | Sell |
139,522
-33,759
| -19% | -$490K | ﹤0.01% | 2729 |
|
2022
Q2 | $1.71M | Buy |
173,281
+110,311
| +175% | +$1.09M | ﹤0.01% | 2891 |
|
2022
Q1 | $928K | Buy |
62,970
+45,564
| +262% | +$671K | ﹤0.01% | 3819 |
|
2021
Q4 | $230K | Sell |
17,406
-23,256
| -57% | -$307K | ﹤0.01% | 5367 |
|
2021
Q3 | $710K | Sell |
40,662
-35,186
| -46% | -$614K | ﹤0.01% | 4165 |
|
2021
Q2 | $1.82M | Buy |
75,848
+30,437
| +67% | +$730K | ﹤0.01% | 3313 |
|
2021
Q1 | $1.17M | Buy |
+45,411
| New | +$1.17M | ﹤0.01% | 3758 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 5335 |
|
2020
Q2 | – | Sell |
-93,503
| Closed | -$715K | – | 5009 |
|
2020
Q1 | $715K | Buy |
+93,503
| New | +$715K | ﹤0.01% | 3132 |
|
2019
Q4 | – | Sell |
-10,194
| Closed | -$118K | – | 4875 |
|
2019
Q3 | $118K | Sell |
10,194
-10,878
| -52% | -$126K | ﹤0.01% | 4231 |
|
2019
Q2 | $467K | Buy |
+21,072
| New | +$467K | ﹤0.01% | 3583 |
|
2016
Q3 | – | Sell |
-1,923
| Closed | -$18K | – | 3808 |
|
2016
Q2 | $18K | Buy |
+1,923
| New | +$18K | ﹤0.01% | 3227 |
|
2015
Q3 | – | Sell |
-279
| Closed | -$28K | – | 4160 |
|
2015
Q2 | $28K | Buy |
+279
| New | +$28K | ﹤0.01% | 3534 |
|